 |
|
Immunolocalization of 5 -Reductase Isozymes in Acne Lesions and Normal Skin
Diane Thiboutot, MD;
Ellen Bayne, PhD;
Jen Thorne, BA;
Kathyrn Gilliland, BS;
Jamie Flanagan, BS;
Qing Shao, MD;
Jan Light, LPN;
Klaus Helm, MD
Arch Dermatol. 2000;136:1125-1129.
Background Dihydrotestosterone mediates androgen-dependent diseases, such as acne, hirsutism, and androgenetic alopecia. This hormone is produced from testosterone by the 5 -reductase enzyme. There are 2 isozymes of 5-reductase (types 1 and 2) that differ in their localization within the body and even within the skin. Activity of the type 1 isozyme predominates in sebaceous glands, where it may be involved in regulation of sebum production. Since specific inhibition of 5-reductase type 1 may represent a novel therapeutic approach to acne, it is important to define the localization of these isozymes in normal sebaceous follicles and acne lesions.
Observations Skin biopsy specimens were obtained from the backs of 11 subjects: 8 with acne and 3 without acne. Sections of normal follicles, open comedones, closed comedones, and inflammatory lesions were incubated with antibodies to types 1 and 2 5-reductase. In all samples, the type 1 antibody localized specifically to sebaceous glands, and the type 2 antibody localized to the companion layer of the hair follicle (the innermost layer of the outer root sheath) and granular layer of the epidermis. Localization of the type 2 isozyme was also noted within the walls of open and closed comedones and in endothelial cells from sections of inflammatory lesions.
Conclusions The immunolocalization of 5-reductase isozymes in normal sebaceous follicles and acne follicles is similar to the pattern described in terminal hair follicles and corresponds with the findings of biochemical studies that have demonstrated predominance of type 1 activity in sebaceous glands. The function of type 2 5-reductase in comedones or endothelial cells in inflammatory lesions is unknown.
From the Section of Dermatology (Drs Thiboutot and Helm and Mss Gilliland and Light) and the Medical School (Ms Thorne), Pennsylvania State University College of Medicine, Hershey; and Merck Research Laboratories, Rahway, NJ (Drs Bayne and Shao and Ms Flanagan).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2000;136(9):1182-1183.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Androgens modulate the inflammatory response during acute wound healing
Gilliver et al.
J. Cell Sci. 2006;119:722-732.
ABSTRACT
| FULL TEXT
|
